首页 › 基金 › Nantahala Capital Management, LLC › USNA
Nantahala Capital Management, LLC 对 USNA 的持仓历史
ENDOVIA HEALTH SCIENCES · 医疗保健
Nantahala Capital Management, LLC 在 Q2 2026 的 13F 申报中披露持有 USNA(ENDOVIA HEALTH SCIENCES)810,074 股,市值约 US$17.3M,约占其申报组合的 0.69%,在其申报持仓中市值排名第 38 位。 Nantahala Capital Management, LLC 最近 3 个申报季度中有 3 个季度披露了 USNA 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Nantahala Capital Management, LLC 对 USNA 的持仓演变
Nantahala Capital Management, LLC 于 Q4 2025 首次披露 USNA 持仓:585,074 股(约 US$11.5M)。 该持仓在 Q2 2026 达到峰值 810,074 股,市值约 US$17.3M。 在 3 次申报中,Nantahala Capital Management, LLC 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 810,074 股、市值约 US$17.3M。 持仓曾出现大幅变动:Q1 2026 增持约 38% (随后一个季度股价上涨 22%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 585.07K | $11.49M | 新进 |
| Q1 2026 | 810.07K | $14.15M | 增持 |
| Q2 2026 | 810.07K | $17.30M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 USNA 与 13F 数据
USNA(ENDOVIA HEALTH SCIENCES)属于医疗保健行业。我们追踪的基金中还有 17 只申报持有 USNA。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Nantahala Capital Management, LLC
常见问题
How long has Nantahala Capital Management, LLC held USNA?
Nantahala Capital Management, LLC has disclosed USNA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Nantahala Capital Management, LLC's current position in USNA?
As of Q2 2026, Nantahala Capital Management, LLC holds 810.07K shares of USNA (ENDOVIA HEALTH SCIENCES), valued at $17.30M, representing 0.69% of its reported portfolio and ranking #38.
Has Nantahala Capital Management, LLC been buying or selling USNA?
In the latest 13F filing (Q2 2026), Nantahala Capital Management, LLC held unchanged its position in USNA. The position peaked in Q2 2026 at 810.07K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.